The difference between prednisone tablets and methylprednisolone tablets
Feb 22, 2023
Source: Cainiu Health
Dr. Liu Aihua
Introduction
The main differences between prednisone tablets and methylprednisolone tablets lie in their pharmacological activity, metabolic pathways, and indications. Prednisone tablets can reduce the pharmacological activity of mast cells during allergic reactions, maintain the stability of lysosomal membranes, and prevent the release of hydrolytic enzymes from polymorphonuclear lysosomes. After administration, prednisone tablets must be metabolized in the liver to become pharmacologically active.
The main differences between prednisone tablets and methylprednisolone tablets lie in their pharmacological activity, metabolic pathways, and indications.
1. Pharmacological Activity
Prednisone tablets can reduce the pharmacological activity of mast cells during allergic reactions, maintain the stability of lysosomal membranes, and prevent the release of hydrolytic enzymes from polymorphonuclear lysosomes. Methylprednisolone tablets effectively control inflammation caused by both infectious and non-infectious conditions. In the acute phase, they inhibit capillary dilation, prevent inflammatory cells from migrating to inflamed areas, block reactions mediated by inflammatory substances, and suppress phagocyte function.
2. Metabolic Pathways
After entering the body, prednisone must be metabolized in the liver into its active form, prednisolone, to exert its pharmacological effects. Methylprednisolone does not require hepatic metabolism, thus posing a lower risk of liver damage. For patients with impaired liver function, methylprednisolone may cause fewer side effects.
3. Different Indications
Prednisone tablets are used to treat allergic and autoimmune inflammatory diseases such as connective tissue diseases, systemic lupus erythematosus, severe polymyositis, serious allergic disorders, acute leukemia, malignant lymphoma, and adrenal cortical hormone therapy. Methylprednisolone tablets are indicated for systemic lupus erythematosus, systemic dermatomyositis, acute rheumatic myocarditis, and other rheumatic diseases, offering potent anti-inflammatory effects.
In addition, the half-lives of prednisone and methylprednisolone differ: the half-life of prednisone is approximately 60 minutes, while that of methylprednisolone is around 180 minutes.
